Amifampridine
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Amifampridine and local guidelines before prescribing.
Potassium-channel blocker
Mechanism
Potassium-channel blocker.
Uses
Lambert-Eaton myasthenic syndrome.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Paraesthesia, seizures, nausea, arrhythmia.
Interactions
QT-prolonging drugs.
Contraindications and cautions
Epilepsy
Monitoring
ECG
Pregnancy and breastfeeding
Avoid
Renal and hepatic impairment
Reduce dose in renal and hepatic impairment
Overdose and reversal
Supportive
Special advice
ECG monitoring.
More from the textbook: uses, cautions and other points
- Lambert–Eaton - treat the cancer; amifampridine (increases acetylcholine release).
Neurology: Anatomy, Physiology and Pharmacology - Amifampridine (3,4-diaminopyridine) - increases acetylcholine release.
Neurology: Neuromuscular disease - Amifampridine | Lambert–Eaton syndrome.
Neurology: Neuromuscular disease
Where it is discussed in the book
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Neuromuscular disease (2 mentions)